Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/12/964   
Active ingredient: Oleylphosphocholine
Indication: Treatment of leishmaniasis
Sponsor: Oblita Therapeutics
Rodendijk 40, 2980 Zoersel, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/04/2012 Orphan designation EMA/OD/135/11 (2012)2896 of 23/04/2012
3/08/2016 Transfer of orphan designation EMA/OD/135/11/T/01 (2016)5125 of 1/08/2016